Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes

Similar documents
Importance of the third arterial graft in multiple arterial grafting strategies

Analysis of Mortality Within the First Six Months After Coronary Reoperation

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

SUPPLEMENTAL MATERIAL

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Unprotected LM intervention

Form 4: Coronary Evaluation

Safe Approach for Redo Coronary Artery Bypass Grafting Preventing Injury to the Patent Graft to the Left Anterior Descending Artery

Coronary artery bypass grafting (CABG) is a temporary treatment for a

Original Article. Abstract. Introduction

Declaration of conflict of interest NONE

Form 4: Coronary Evaluation

Changing profile of patients undergoing redo-coronary artery surgery q

The MAIN-COMPARE Study

The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting

Emergency surgery in acute coronary syndrome

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI

Coronary Artery Disease: Revascularization (Teacher s Guide)

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

J. Schwitter, MD, FESC Section of Cardiology

TSDA ACGME Milestones

Long-term cardiac survival after reoperative coronary artery bypass grafting

Coronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid?

Alex versus Xience Registry Preliminary report

The MAIN-COMPARE Registry

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

APPENDIX F: CASE REPORT FORM

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

CABG Surgery following STEMI

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

Myocardial enzyme release after standard coronary artery bypass grafting

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

Management of High-Risk CAD : Surgeons Perspective

Technical Aspects and Initial Experience in Off-Pump Coronary Artery Bypass Grafting

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

EACTS Adult Cardiac Database

Minimally invasive direct coronary artery bypass for left anterior descending artery revascularization analysis of 300 cases

Supplementary Table S1: Proportion of missing values presents in the original dataset

Form 4: Coronary Evaluation

Ischemic Ventricular Septal Rupture

Setting The setting was a hospital. The economic study was carried out in Australia.

Form 4: Coronary Evaluation

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece

Results of Reoperation

The use of both the left and right internal thoracic arteries (ITAs) for revascularization

Coronary interventions

The most important advantage of CABG over PTCA is its

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Myocardial revascularization without cardiopulmonary

Cardiogenic Shock. Carlos Cafri,, MD

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

A COMPARISON OF CORONARY ANGIOGRAPHY RESULTS IN PATIENTS WITH STABLE AND UNSTABLE ANGINA PECTORIS

Curriculum Vitae. Saeed Alipour Parsa, M.D., Associate Professor of Cardiology

Common Codes for ICD-10

Supplementary Material to Mayer et al. A comparative cohort study on personalised

Diabetes mellitus (DM) has been identified as an independent

Percutaneous coronary intervention of RIMA. The real challenge!

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Anatomy of the Heart and the. ICD-10 Codes

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view

OPCABG for Full Myocardial Revascularisation How we do it

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE

Retrospective Study Of Redo Cardiac Surgery In A Single Centre. R Karthekeyan, K Selvaraju, L Ramanathan, M Rakesh, S Rao, M Vakamudi, K Balakrishnan

Early results after myocardial revascularization without cardiopulmonary bypass

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Prolonged Oral Morphine Therapy for Severe Angina Pectoris

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S.

Disclosures The PREVENT IV Trial was supported by Corgentech and Bristol-Myers Squibb

Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation?

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

PROMUS Element Experience In AMC

Extra Corporeal Life Support for Acute Heart failure

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Although current methods of cardiopulmonary bypass

FFR in Multivessel Disease

Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery

INTRODUCTION. Key Words:

Zachary I. Hodes, M.D., Ph.D., F.A.C.C.

Flexibility of the COMBO Dual Therapy Stent

Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California

Coronary arteriography in complicated acute myocardial infarction; clinical and angiographic correlates

Ischemic Mitral Regurgitation

Preoperative Cardiac Risk Assessment: Approach & Guidelines

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results

Transcription:

Original Article Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes AR Jodati, MA Yousefnia From Department of Cardiothoracic Surgery, Madani Heart Hospital, Tabriz University of Medical Sciences, Tabriz, Iran. Correspondence: Dr. AR. Jodati, Assistant professor, Department of cardiothoracic surgery, Madani Heart Hospital, Tabriz, Iran. E-mail: Mosharkesh@yahoo.com Received: October 27, 27 Accepted: November 22, 27 ABSTRACT Objectives: To study the Redo CABG (Coronary Artery Bypass Graft) in patients admitted in Shahid Rajaei Heart Hospital in Tehran, Iran. Materials and Methods: This study was carried out by reviewing patients' records who had undergone Redo CABG in Shahid Rajaei Heart Hospital in Tehran, Iran from 22 to 26. This descriptive study was done on 72 patients. Demographic data, risk factors, indications for Redo operation, ejection fraction, mortality, morbidity and events after Redo operation were collected. The statistical analysis was based on the SPSS software through descriptive statistical method. Results: The prevalence of Redo CABG was 1.72%. Reducing Ejection Fraction (EF) between two operation and stable angina were the most common factors requiring Redo operation. Postoperative morbidity and mortality were higher in Redo CABG Conclusion: Recurrent ischemia required Redo CABG with higher mortality and morbidity. It is suggested to make dedicated centers with specially trained personnel to do Redo CABG. (Rawal Med J 28;33:36-39). Key words: Redo CABG, arteriosclerotic disease, risk factors, outcome of surgery. INTRODUCTION The most prevalent intervention after Coronary Artery Bypass Graft (CABG) operation is second CABG operation. Although Percutaneous Coronary Intervention (PCI) is being done in 25% of patients after CABG operation, in some countries secondary CABG operations are also increased. It is estimated that this will reach 9% in 1 years and 65% in 15 years. 1 Some factors which affects the initiation of conditions for secondary bypass and time to perform the said operation are conduit and young age of the patient at the time of first operation, better performance of left ventricles and atherosclerosis of grafted veins. 2 Use of Internal Thoracic Artery (ITA) in anastomoses to Left Anterior Descending (LAD) causes considerable reduction of requirement of repeated operation and has increased the period between first and second bypass operation. 1 Angina still is the main reason for necessity of first and second CABG operations. Recovery symptoms after second CABG operation specially were very successful as experience of Cleveland Clinic showed. 2 The aim of this study was to review the Redo CABG in patients admitted in Shahid Rajaei Heart Hospital in Tehran, Iran. The 1

specific aims were evaluation of any rise in number of Redo CABG, mean period between two operations, EF in Redo operation, clinical symptoms, comparison of findings in angiography in first and second operation, and to find out if any relationship existed between risk factors and time period between first and second operation. METHODS In this descriptive and retrospective study performed between 22 to 26, medical records of 72 patients referred for coronary bypass operation were evaluated for age, gender, period between first and secondary operation, clinical symptoms in both the operations, risk factors, EF, coronary vein angiography and grafted vein status in second angiography. Risk factors noted included hyperlipidemia (cholesterol > 2 mg/dl), diabetes (fasting blood sugar > 14 mg/dl), hypertension (BP>14/9), history of consumption of antihypertensive drugs, smoking (regular use of one cigarette everyday in last 2 years) and family history (sudden death myocardial infarction) in first degree relative. Statistical analysis was performed using SPSS Program and P<.5 was considered significant. RESULTS Amongst 4178 CABG operations performed during 22-26, only 72 (1.72%) Redo CABG operations were performed. 88.9% of patients were males and 11.1% females. Age of patients in first CABG operation ranged from 28 to 7 years (mean 48.16±8.17), while in second CABG it ranged from 38 to 78 years (mean 58.67±8.43). EF in first operation was between 3 and 77 (mean 52.33±9.68) and in second operation 2 and 65 % (mean 43.7±11.84). Clinical symptoms in first operation included stable angina (79.2%), unstable angina (2.8%), myocardial infarction (19.4%) and congestive heart failure (1.4%). These in repeat operation were stable angina (87.5%), unstable angina (2.8%), myocardial infarction (6.9%) cardiogenic shock (2.8%) and congestive heart failure (1.4%). First operation was performed in 97.2% of patients as elective and in 2 patients (2.8%) in urgent condition, where as in Redo CABG, 9.3% of patients were in elective, 5.6% urgent and 1.4 in emergency conditions, while in 2 patients it was not clear. Risk factors worsened in second operation except smoking (table 1). Table 1. Prevalence of risk factors in two groups Variables First operation (%) Second operation (%) P Value IDDM 1.4 2.8.93 NIDDM 6.9 22.2.65 Hypertension 4.2 16.7.81 Elevated Triglycerids 8.3 29.2.1 Smoking 26.4 2.8.74 Elevated LDL 4.2 4.3.6 Family history of CAD 15.3 19.4.17 Other, Such as cancer 1.4 4.2.36 Renal insufficiency - 5.6.62 IDDM: Insulin Dependent Diabetes Mellitus, NIDDM: Non Insulin Dependent Diabetes Mellitus, LDL: Low Density Lipoprotein, CAD: Coronary Artery Disease 2

Angiographic evaluation showed that the arteriosclerosis in veins of native vessels was increased in 2 nd operation. Table 2. Arteriosclerosis obstructed veins in 1 st and 2 nd operation by angiographic studies. Variables First operation (%) Second operation (%) P Value LM 6.9 23.6.4 LCX 38.9 7.8.1 OM1 22.2 3.6.18 OM2 8.3 15.3.3 LAD 79.2 95.8.2 D 25 27.8.82 RCA 62.5 87.5.1 PDA 5.6 9.7.45 LM: Left Main Coronary, LCX: Left Circumflex, OM1: Obtus Marginalis, OM2: Obtus Marginalis, LAD: Left Anterior Descending, D: Diagonal, RCA: Right Coronary Artery, PDA: Posterior Descending Artery Most grafts were performed on LAD (table 3). Condition of grafted vein in 1st and 2nd operation, in angiographic study, showed that 85.3 % of these grafts were completely closed, 8.3% were having narrowed veins and 5.6% were completely open. The rest of the grafts in.8% were having intermediate situation. But among ITA grafts only 9.7% were completely blocked, 18.1% with constriction. Table 3. Incidence of graft performed in 1 st and 2 nd operation. Variables First operation (%) Second operation(%) LCX 4.2 1.4 OM1 26.4 56.9 OM2 22.2 31.9 LAD 73.6 8.6 D 26.4 48.8 RCA 45.8 38.9 PDA 13.9 25.8 LCX: Left Circumflex, OM1: Obtus Marginalis, OM2: Obtus Marginalis, LAD: Left Anterior Descending, D: Diagonal, RCA: Right Coronary Artery, PDA: Posterior Descending Artery Further studies performed on grafted veins during operation showed that 75% of them were completely occluded and 4.2% had stenosis. Incidence of adhesions due to first CABG showed that 59.7% had mild adhesions while, 13.9% had moderate and 23.6% severe adhesions. Cannulation in 86.1% of patients was from aorta, and 4.2% from femoral artery. 3

14 12 1 8 6 4 2 4.2 Intra Operative bleeding 8.3 2.8 1.4 Re bleeding Peri operative MI 8.3 Low cardiac out put 4.2 Neurologic event 1.4 13.9 Infection 2.8 1.4 Ventricular arrhythmias First Operation Second Operation Fig 1. Incidence of morbidity in first and second operation Infection was most common postoperative complication (Fig 1). It included 14% mediastinitis, pluritis and infection on lower limbs. Duration of hospitalization in ICU after first operation was 2.8±.29 days while, for second operation 3.53±3.68 days. Average hospitalization was 14.33±7.9 and 15.81±9.76 days for first and second operation respectively. Hospital morbidity in Redo operation was approximately 3.3%, which was due to heart problems. CPB time at the first operation was 19±29.41 minutes and in the second operation, it was 12.31±33.86 minutes. Aortic cross clamp time in the first operation was 64.67±16.43 minutes and in second operative it was 51±18.91 minutes. Among first CABG operations, 36.1% of them were accomplished abroad like United Kingdom, France, Germany and Switzerland, 48.6% in central university hospitals of native country while, only 8.3%were in private centers. PTCA for dilating the constriction before Redo operation was performed in 9.7% of patients. Indication of second operation included incomplete revascularization (1.7%), 25% graft failure, 6.9% advanced atherosclerosis of native vessels, 19.4% advanced graft and was observed in 47.3% patients. Secondary coronary bypass operation in 94.4% was by means of midsternotomy 1.4% by right thoracotomy, s 1.4% was by left thoracotomy in 2 cases is not clear. Out of 72 patients, 69 were operated by CPB and only 4.2% of patients was operated by off pump method. Risk factors were not statistically significantly different. DISCUSSION Main etiology of Redo CABG, are recurrent ischemia due to advancement of atherosclerosis in native vessels of first operated graft, or incomplete revascularization. 3 Studies have shown that 1-2% of patients operated for CABG operation, in first 1 years of their first operation require Redo CABG operation. 4 Studies of reoperative risk have focussed on surgical techniques. We sought to determine the risk and predictors of poor outcome in current practice, and the influence of preoperative symptoms. 5 The prevalence of Redo CABG in 4187 CABG operation was only 1.72%. Our mortality within 3 day after operation was 3.3%. These patients had LVEF less than 3 and were diabetic patients. Surgical morbidity in Redo CABG has been reported to be significantly higher as compare to first CABG operation. 6,7 In the secondary operation factors like anatomical changes, due to previous operation, hypertension, old age as compare to first operation and development of 4

risk factors like reduction of LVEF were the cause of increasing the complications. In this study, the average of age of patients in first operation was 48.16±8.17 and in second was increase to 58.67±8.43years. The average of LVEF decreased from 52.33±9.68 to first operation to 43.7±11.84 in 2 nd operation. Infection of operation site was 1.4% in first and was increased to 13.9% in Redo operation. Once patients survived the first 6 postoperative months, advanced age (>65 years) is affecting long term cardiac survival and impaired left ventricular function is the only independent predictor of late cardiac mortality. 8 Off pump Redo CABG has been safely performed with a relatively low mortality rate and a low rate of target lesion revascularization. 9 High risk subgroup of patients, who underwent target vessel revascularization without CPB showed a trend toward a lower rate of major adverse cardiac events. 1 Complete revascularization, without damaging the heart, whichever technique is used, is the target of Redo surgery, to achieve the same quality of results obtained in the first operation. 11 Age older than 75 years and NYHA class IV are risk factors for early mortality. 12 Non availability of complete information in the patient files and less Redo operation in recent year is one of the factors which limited the comparison of our operation with the famous centers abroad. In conclusion, recurrent ischemia required Redo CABG with higher mortality and morbidity Special center with expert manpower for the managing of Redo CABG operation is required in our country. REFERENCES 1. Sabition DC, Spencer FC. Surgery of the chest. 6 th ed. Philadelphia: Saunders, 1995. p.1925-4. 2. Yau TM, Borger MA, Weisel RD, Ivanov J. The changing pattern of reoperative coronary surgery: trends in 123 consecutive re operatins. J Thorac Cardiovasc Surg. 2; 12:156-63. 3. Masoumi Y, Bruce WL Shelly KS, Delos MC, Flyd DL, Patrick MM. Risk factors and outcomes after coronary reoperation in 739 elderly patients. Ann Thorac Surg. 2; 69: 464-74. 4. Itzhak S, Aharon I, Israel H, Marcel T, Amos P. Long-term follow-up after coronary artery bypass grafting reoperation. Chest 1999; 115:1593-97. 5. Ngaage DL, Cowen ME, Griffin S, Guvendik L, Cale AR. The impact of symptom severity on cardiac reoperative risk: early referral and reoperation is warranted. Eur J Cardiothorac Surg. 27; 32:623-8. 6. Hausmann H, Topp H, Siniawski H, Holz S, Hetzer R. Decision-making in end-stage coronary artery disease: revascularization or heart transplantation? Ann Thorac Surg. 1997;64:1296-31. 7. Christenson JT, Badel P, Simonet F, Schmuziger M. Pre-operative IABP enhances cardiac performance and improves the outcome of Redo CABG. Ann Thorac Surg. 1997; 64:1237-44. 8. Noyez L, Frans M. Long term cardiac survival after reoperation coronary artery 5

bypass grafting. Eur J Cardiothorac Surg. 24;25:59-64. 9. Stamou SC, Pfister A, Dullum MK, Boyce SW, Bafl AS, Lomax T, et al. Late out come of reoperative coronary revascularization on the beating heart. Heart Surg Forum. 21;4:69-73. 1. Czerny M, Zimpfer D, Kllo J, Gottardi R, Wolner E, Grimm M. Redo coronary artery bypass grafting with or without cardiopulmonary bypass in the elderly. Cardiothoracic Multimedia Journal, The heart Surgery Forum 23; 6:21-5. 11. Di Mauro M, Iaco AL, Contini M, Teodori G, Vitolla G, Pano M, et al. Reoperative coronary artery bypass grafting analysis of early and late outcomes. Ann Thorac Surg 25; 79:81-7. 12. Szeto WY, Bavaria JE, Bowen FW, Geirsson A, Cornelius K, Hargrove WC, Pochettino A. Reoperative aortic root replacement in patients with previous aortic surgery. Ann Thorac Surg. 27;84:1592-8. 6